- About Breast Cancer
- Community Impact
- Get Involved
OUR IMPACT IN THE MISSION TO END BREAST CANCER
WHERE DO OUR PROCEEDS GO?
Amy Lynn Shares the Importance of Early Detection
Amy Lynn reminds us why early detection and knowing your normal is so important.For women with genetic risk, twice-a-year MRI beats mammograms
NewsWise: A Komen-funded study – including Komen Scholar Dr. Mary Claire King and led by Komen Scholar Dr. Olufunmilayo Olopade – showed that getting….SEE ALL NEWS
TailorRX study shows chemotherapy not needed for some breast cancer patients. Hear from our very own Dr. Sledge. Watch Now!Metastatic Breast Cancer
Komen has invested more than $180 million into research on metastatic breast cancer. Find out what we’ve learned and what we’re investigating. Read more now!